Trials / Completed
CompletedNCT04309331
Market Research - Acceptability Trial for a New PKU Amino Acid Based Protein Substitute
Market Research - Acceptability Trial for a New PKU Amino Acid Based Protein Substitute (Dr Schär Medical Nutrition - Mevalia Amino Acids) Mevalia PKU Motion 10 - Tropical or Red Fruits Mevalia PKU Motion 20 - Tropical or Red Fruits
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Dr. Schär AG / SPA · Industry
- Sex
- All
- Age
- 3 Years – 16 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to demonstrate that a new protein substitute is acceptable and well tolerated in children with PKU.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Motion | Amino acid based protein substitute |
Timeline
- Start date
- 2018-07-01
- Primary completion
- 2018-09-19
- Completion
- 2018-09-19
- First posted
- 2020-03-16
- Last updated
- 2020-03-16
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT04309331. Inclusion in this directory is not an endorsement.